Detalles de la búsqueda
1.
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial.
Mult Scler
; 29(3): 427-435, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550636
2.
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis.
Value Health
; 26(4): 519-527, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764517
3.
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force.
Value Health
; 26(4): 449-460, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005055
4.
Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison.
BMC Med Inform Decis Mak
; 20(1): 114, 2020 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32560655
5.
Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms.
Value Health
; 22(9): 1063-1069, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511183
6.
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.
BMC Med Inform Decis Mak
; 19(1): 189, 2019 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31585538
7.
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.
Value Health
; 19(6): 746-750, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27712701
8.
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
Pharmacoepidemiol Drug Saf
; 24(12): 1233-40, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26456379
9.
Benefit-risk assessment of vaccines.
Vaccine
; 42(4): 969-971, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563049
10.
How to Present a Decision Object in Health Preference Research: Attributes and Levels, the Decision Model, and the Descriptive Framework.
Patient
; 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341385
11.
Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey.
Patient
; 17(2): 147-159, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085458
12.
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
J Am Heart Assoc
; 13(8): e032782, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563380
13.
A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.
Clin Pharmacol Ther
; 115(6): 1251-1257, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506485
14.
The Brighton collaboration standardized module for vaccine benefit-risk assessment.
Vaccine
; 42(4): 972-986, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135642
15.
Pain qualities and satisfaction with therapy: a survey of subjects with neuropathic pain.
Pain Med
; 14(11): 1745-56, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889910
16.
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies.
Ann Gen Psychiatry
; 12(1): 22, 2013 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23845018
17.
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment.
Mult Scler J Exp Transl Clin
; 9(1): 20552173221150370, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714174
18.
Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions.
MDM Policy Pract
; 8(1): 23814683221148715, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36654678
19.
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action.
Front Pharmacol
; 14: 1192770, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37663265
20.
U.S. Food and Drug Administration's Patient-Focused Drug Development Initiative: Experience with Integration of Patient-Experience Data in a New Drug Application for Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant for Treatment-Resistant Depression.
Ther Innov Regul Sci
; 56(1): 38-46, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34623613